BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 25809746)

  • 1. Tumor oncogene (KRAS) status and risk of venous thrombosis in patients with metastatic colorectal cancer.
    Ades S; Kumar S; Alam M; Goodwin A; Weckstein D; Dugan M; Ashikaga T; Evans M; Verschraegen C; Holmes CE
    J Thromb Haemost; 2015 Jun; 13(6):998-1003. PubMed ID: 25809746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of venous thromboembolism in patients with colorectal cancer according to oncogenic status.
    Ortega Morán L; García Alfonso P; Aguilar Caballero I; Morón García B; Tirado Anula V; de Toro Carmena M; Soto Alsar J; Gutiérrez Alonso N; Bringas Beranek M; Martín Jiménez M; Muñoz Martín AJ
    Clin Transl Oncol; 2020 Nov; 22(11):2026-2031. PubMed ID: 32270416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of RAS mutations and individual variation patterns among patients with metastatic colorectal cancer: A pooled analysis of randomised controlled trials.
    Peeters M; Kafatos G; Taylor A; Gastanaga VM; Oliner KS; Hechmati G; Terwey JH; van Krieken JH
    Eur J Cancer; 2015 Sep; 51(13):1704-13. PubMed ID: 26049686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial.
    Tabernero J; Lenz HJ; Siena S; Sobrero A; Falcone A; Ychou M; Humblet Y; Bouché O; Mineur L; Barone C; Adenis A; Yoshino T; Goldberg RM; Sargent DJ; Wagner A; Laurent D; Teufel M; Jeffers M; Grothey A; Van Cutsem E
    Lancet Oncol; 2015 Aug; 16(8):937-48. PubMed ID: 26184520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prevalence of Symptomatic Deep Venous Thrombosis and Pulmonary Embolism After Anterior Cruciate Ligament Reconstruction.
    Gaskill T; Pullen M; Bryant B; Sicignano N; Evans AM; DeMaio M
    Am J Sports Med; 2015 Nov; 43(11):2714-9. PubMed ID: 26391861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRAS mutations in tumor tissue and plasma by different assays predict survival of patients with metastatic colorectal cancer.
    Xu JM; Liu XJ; Ge FJ; Lin L; Wang Y; Sharma MR; Liu ZY; Tommasi S; Paradiso A
    J Exp Clin Cancer Res; 2014 Dec; 33(1):104. PubMed ID: 25491325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison among different presentations of venous thromboembolism because of lung cancer.
    Guo J; Deng QF; Xiong W; Pudasaini B; Yuan P; Liu JM; Zhou CC
    Clin Respir J; 2019 Sep; 13(9):574-582. PubMed ID: 31306554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial fibrillation associated with increased risk of venous thromboembolism. A population-based cohort study.
    Wang CC; Lin CL; Wang GJ; Chang CT; Sung FC; Kao CH
    Thromb Haemost; 2015 Jan; 113(1):185-92. PubMed ID: 25318828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review and meta-analysis of incidence, prognosis, and laboratory indicators of venous thromboembolism in hospitalized patients with coronavirus disease 2019.
    Liu Y; Cai J; Wang C; Jin J; Qu L
    J Vasc Surg Venous Lymphat Disord; 2021 Sep; 9(5):1099-1111.e6. PubMed ID: 33529719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of venous thromboembolism on the natural history of pancreatic adenocarcinoma.
    Ouaissi M; Frasconi C; Mege D; Panicot-Dubois L; Boiron L; Dahan L; Debourdeau P; Dubois C; Farge D; Sielezneff I
    Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):436-42. PubMed ID: 26256090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous Thromboembolism in Necrotizing Pancreatitis: an Underappreciated Risk.
    Roch AM; Maatman TK; Carr RA; Colgate CL; Ceppa EP; House MG; Lopes J; Nakeeb A; Schmidt CM; Zyromski NJ
    J Gastrointest Surg; 2019 Dec; 23(12):2430-2438. PubMed ID: 30734182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of KRAS Mutation in Colorectal Cancer-Associated Thrombosis.
    Emilescu RA; Jinga M; Cotan HT; Popa AM; Orlov-Slavu CM; Olaru MC; Iaciu CI; Parosanu AI; Moscalu M; Nitipir C
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating Venous Thromboembolism Risk in Metastatic Colorectal Cancer Inpatients: Validation of Existing Risk Scores and Development of New Risk Scores.
    Qin L; Liang Z; Xie J; Li X
    Clin Appl Thromb Hemost; 2023; 29():10760296231196859. PubMed ID: 37691565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic perioperative venous thromboembolism is a frequent complication in patients with a history of deep vein thrombosis.
    Liem TK; Huynh TM; Moseley SE; Minjarez RC; Landry GJ; Mitchell EL; Deloughery TG; Moneta GL
    J Vasc Surg; 2010 Sep; 52(3):651-7. PubMed ID: 20558025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thromboembolic events in patients undergoing craniotomy for tumor resection: incidence, predictors, and review of literature.
    Rinaldo L; Brown DA; Bhargav AG; Rusheen AE; Naylor RM; Gilder HE; Monie DD; Youssef SJ; Parney IF
    J Neurosurg; 2019 Jan; 132(1):10-21. PubMed ID: 30611138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study.
    Cohen AT; Katholing A; Rietbrock S; Bamber L; Martinez C
    Thromb Haemost; 2017 Jan; 117(1):57-65. PubMed ID: 27709226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving selection of patients with metastatic colorectal cancer to benefit from cetuximab based on KIR genotypes.
    Manzanares-Martin B; Cebrián Aranda A; Del Puerto-Nevado L; González R; Solanes S; Gómez-España MA; García-Foncillas J; Aranda E
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33833048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of NRAS mutations as prognostic and predictive markers in metastatic colorectal cancer.
    Schirripa M; Cremolini C; Loupakis F; Morvillo M; Bergamo F; Zoratto F; Salvatore L; Antoniotti C; Marmorino F; Sensi E; Lupi C; Fontanini G; De Gregorio V; Giannini R; Basolo F; Masi G; Falcone A
    Int J Cancer; 2015 Jan; 136(1):83-90. PubMed ID: 24806288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term risk of venous thromboembolism recurrence after isolated superficial vein thrombosis.
    Galanaud JP; Sevestre MA; Pernod G; Kahn SR; Genty C; Terrisse H; Brisot D; Gillet JL; Quéré I; Bosson JL
    J Thromb Haemost; 2017 Jun; 15(6):1123-1131. PubMed ID: 28317330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-Specific Risk Factors for Deep Venous Thrombosis and Pulmonary Embolism in a Population-Based Historical Cohort Study of Middle-Aged and Older Individuals.
    Brink A; Elf J; Svensson PJ; Engström G; Melander O; Zöller B
    J Am Heart Assoc; 2023 Mar; 12(5):e027502. PubMed ID: 36847045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.